Results 221 to 230 of about 354,007 (274)
Some of the next articles are maybe not open access.

Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma

Allergy, 2001
Cysteinyl leukotrienes, synthesized de novo from cell membrane phospholipids, are proinflammatory mediators that play an important role in the pathophysiology of asthma. These mediators are among the most potent of bronchoconstrictors and cause vasodilation, increased microvascular permeability, exudation of macromolecules and edema.
openaire   +2 more sources

The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field

European Journal of Clinical Pharmacology, 2017
M. Hoxha, G. Rovati, A. B. Cavanillas
semanticscholar   +1 more source

The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling.

Pulmonary Pharmacology & Therapeutics, 2018
Jung‐Mu Hur   +4 more
semanticscholar   +1 more source

Role of Leukotrienes and Leukotriene Receptor Antagonists in Asthma

Pulmonary Pharmacology & Therapeutics, 1999
T R, Jones, I W, Rodger
openaire   +2 more sources

Role of leukotriene receptor antagonists in pediatric asthma

Pediatric Pulmonology, 2000
During the past decade, the inflammatory mechanisms that result in the clinical syndrome we call asthma have been emphasized in research, publications, and the various asthma management guidelines. This information clearly emphasizes the treatment of asthma with maintenance controller therapies early after the onset of symptoms in all but the very ...
openaire   +2 more sources

Cysteinyl leukotriene receptor antagonist epigenetically modulates cytokine expression and maturation of human myeloid dendritic cells.

Pulmonary Pharmacology & Therapeutics, 2016
Chang-Hung Kuo   +8 more
semanticscholar   +1 more source

Leukotriene receptor antagonists. III. Pharmacological and chemical studies with LY137617, a leukotriene D4 and leukotriene E4 receptor antagonist.

Drugs under experimental and clinical research, 1989
A series of chlorophenoxyalkyl acids were prepared and evaluated as pharmacological antagonists of leukotriene D4. Structure-activity relationship studies pointed to LY137617 as a compound with possible therapeutic value. In experiments on isolated smooth muscles from the guinea-pig, this agent was a selective and moderately potent antagonist of ...
D K, Herron   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy